期刊文献+

奥美拉唑胃溶速释片的制备及处方研究 被引量:2

Preparation of Omeprazole Gastric Immediate Release Tablets and Study on the Formulation Thereof
下载PDF
导出
摘要 目的:制备奥美拉唑胃溶速释片,并考察其处方工艺。方法:采用羟丙纤维素为囊材、喷雾干燥法制备奥美拉唑微囊,再与抗酸剂碳酸氢钠和氢氧化镁混合压片。建立HPLC法测定奥美拉唑微囊的包封率及其片剂在模拟胃酸介质中的溶出度,并考察片剂对溶出介质pH的影响,进行处方筛选研究。结果:每片胃溶速释片最优处方:奥美拉唑40 mg,碳酸氢钠350 mg,氢氧化镁600 mg,囊心物与囊材的用量比为1∶2。微囊包封率为92.54%。片剂最大溶出度为75%,奥美拉唑在数分钟内快速溶出,其溶出介质的pH在3.5以上至少可维持30分钟。结论:该制剂在溶出介质中能快速释放奥美拉唑,其中微囊可延缓药物溶出,而抗酸剂可以提高胃内pH值,从而减少奥美拉唑在胃酸性环境的降解。 Objective: To prepare omeprazole (OMZ) gastric immediate release tablets and to investigate the formulation technique thereof. Methods: OMZ microcapsules were prepared using HPC as coating material by spray-drying method and they were compressed together with antacid agents, such as NaHCO3 and Mg(OH)2, after mixing homogeneously. The encapsulation efficiency of OMZ microcapsules and dissolution of OMZ tablets were determined by the established HPLC method. The effect of OMZ tablets on pH of dissolution medium were also evaluated. Therefore, screening of formulation of OMZ tablets was conducted. Results: The optimized formulation per OMZ tablet was obtained, which consisted of OMZ 40 mg, NaHCO3 350 mg, Mg(OH)2 600 mg and OMZ/HPC ratio of 1 : 2. The encapsulation efficiency of OMZ microcapsules was 92. 54%. The maximum dissolution of OMZ tablets was above 75% and OMZ in the tablets was immediately released in a few minutes in dissolution medium. At the same time , the pH value of the dissolution medium remained above 3.5 for 30 min at least. Conclusion: OMZ in the immediate release tablets can be rapidly dissolved in gastric acid medium . The microcapsules can delay dissolution of OMZ in the tablets, the antacid agents can rise pH in gastric juice and therefore the degradation of oral OMZ could be reduced.
出处 《药学进展》 CAS 2007年第12期564-568,共5页 Progress in Pharmaceutical Sciences
关键词 奥美拉唑 羟丙纤维素 微囊化 抗酸剂 胃溶速释片 溶出度 pH值 Omeprazole HPC Microencapsulation Antacid Gasric immediate release tablet Dissolution pH value
  • 相关文献

参考文献5

二级参考文献11

共引文献51

同被引文献30

  • 1张晓晖.膜控型微丸制剂的研究进展[J].北方药学,2009,6(2):25-28. 被引量:2
  • 2ChP 2010.VolⅡ(中国药典2010年版.二部)[S].2010:215. 被引量:2
  • 3Zhang K,Dai L,Chetwyn NP.Simultaneous determination of positive and negative pharmaceutical counterions using mixed-mode chromatography coupled with charged aerosol detector[J].J Chromatogr A,2010,1217(37):5776. 被引量:1
  • 4Huang Z,Richards MA,Zha Y,et al. Determination of inorganic pharmaceutical counterions using hydrophilic interaction chromatography coupled with a Corona CAD detector[J].J Pharm Biomed Anal,2009,50(5):809. 被引量:1
  • 5Haddadin RN,Issa AY.Development and validation of simple titrimetric method for the determination of magnesium content in esomeprazole magnesium[J].Indian J Pharm Sci,2011,73(4):466. 被引量:1
  • 6Nesterenko EP,Nesterenko PN,Paull B.Zwitterionic ion-exchangers in ion chromatography:a review of recent developments[J].Anal Chim Acta, 2009,652(1-2):3. 被引量:1
  • 7Gika H,Theodoridis G,Mattivi F,et al. Hydrophilic interaction ultra performance liquid chromatography retention prediction under gradient elution[J].Anal Bioanal Chem, 2012,404(3):701. 被引量:1
  • 8Dong Q,Zhu J,Sui Q,et al. Optimization of mobile phase for the determination of esomeprazole and related compounds and investigation of stress degradation by LC-MS[J].J Sep Sci,2013,36(7):1200. 被引量:1
  • 9USP 35-NF30.<1225> Validation of Compendial Procedures [S].2014:877. 被引量:1
  • 10Dharuman JG,Vasudevan M.Reliability-targeted HPLC-UV method validation-a protocol enrichment perspective[J].J Sep Sci,2014,37(3):228. 被引量:1

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部